Schedule 13D ownership disclosure
ATHIRA PHARMA INC
Security class unavailable · CUSIP: 04746L104
Event date: 2023-12-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-306018
- Form type
- SC 13D
- Filer
- Athira Pharma, Inc.
- CIK
- CIK 1620463
- Filed
- Dec 29, 2023
- Reporting period
- Dec 27, 2023
- Description
- Schedule 13D beneficial ownership